Philips Unveils Its Connected Health AI Platform at HIMSS26 in Las Vegas
On Tuesday, Royal Philips introduced its strategic approach based on open and interoperable platforms that connect continuous patient monitoring with diagnostic data. The company is showcasing this direction at the HIMSS26 conference in Las Vegas.
Royal Philips is structuring its offerings around two main directions. First, 'enterprise patient monitoring', which aims to create a continuity of physiological data throughout the entire care journey, from acute settings to post-acute contexts and after hospital discharge. Second, the 'Integrated Diagnostics' initiative, designed to unify access to diagnostic imaging data from distinct specialties—radiology, cardiology, pathology—within a single cloud platform. This approach is based on the integration of medical devices, monitoring systems, imaging platforms, and hospital information systems, including electronic medical records and third-party technologies.
Platform Strategy Emphasizes Cybersecurity and Ethical AI
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Philips emphasizes that its platform strategy places cybersecurity, privacy, and responsible AI practices at the core of its framework. The company asserts that trust is a fundamental element that enables data flow within the enterprise, supports a longitudinal understanding of the patient, and facilitates the deployment of AI to enhance clinical decision-making while reducing unnecessary complexity.
SectorSanté · Technologie · Dispositifs médicaux›Équipements Médicaux
Context
Period
Period: 1T2026
Key reported figures
Revenue: 3.9MD€
Free cash flow: 28M€
Guidance from the release
Nous avons délivré un bon départ en 2026.
Bonne performance au T1, croissance des ventes et des marges.
Risks mentioned
Impact des tarifs et inflation des coûts sur les marges.
Environnement macroéconomique incertain impactant les performances.
Opportunities identified
Croissance des ventes comparables de 4% dans tous les segments.
Augmentation du carnet de commandes grâce à des innovations.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
